-+ 0.00%
-+ 0.00%
-+ 0.00%

Mineralys Therapeutics Q4 EPS $(0.40) Beats $(0.58) Estimate

Benzinga·03/12/2026 20:08:23
Listen to the news
Mineralys Therapeutics (NASDAQ:MLYS) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.58) by 30.68 percent. This is a 59.18 percent increase over losses of $(0.98) per share from the same period last year.